Keyphrases
High-dose Therapy
100%
First Relapse
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Multiple Myeloma
100%
Overall Survival
100%
High-dose Chemotherapy
91%
Partial Response
16%
High-risk Cytogenetics
16%
Multiple Myeloma Patients
16%
Best Response
16%
Northern Netherlands
8%
Time to Next Treatment
8%
Novel Agents
8%
Newly Diagnosed multiple Myeloma
8%
First Response
8%
Relapsed or Refractory multiple Myeloma
8%
Transplant-related Mortality
8%
Performance Status
8%
Tertiary Care Hospital
8%
Baseline Characteristics
8%
Novel Therapies
8%
Duration of Response
8%
Re-induction
8%
Mortality Rate
8%
Real-world Outcomes
8%
Consolidation Strategies
8%
Retrospective Cohort Study
8%
Prognostic Factors
8%
Treatment Options
8%
Medicine and Dentistry
Overall Survival
100%
Multiple Myeloma
100%
Autologous Stem Cell Transplantation
100%
Drug Megadose
100%
High Dose Chemotherapy
91%
Mortality Rate
8%
Prognostic Factor
8%
Patient Referral
8%
Retrospective Cohort Study
8%
Biochemistry, Genetics and Molecular Biology
Drug Megadose
100%
Autologous Stem Cell Transplantation
100%
Overall Survival
100%
Cytogenetics
16%
Cohort Study
8%
Mortality Rate
8%
